147 related articles for article (PubMed ID: 35460613)
1. Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax.
Hodder AN; Christensen J; Scally S; Triglia T; Ngo A; Birkinshaw RW; Bailey B; Favuzza P; Dietrich MH; Tham WH; Czabotar PE; Lowes K; Guo Z; Murgolo N; Lera Ruiz M; McCauley JA; Sleebs BE; Olsen D; Cowman AF
Structure; 2022 Jul; 30(7):947-961.e6. PubMed ID: 35460613
[TBL] [Abstract][Full Text] [Related]
2. Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle.
Favuzza P; de Lera Ruiz M; Thompson JK; Triglia T; Ngo A; Steel RWJ; Vavrek M; Christensen J; Healer J; Boyce C; Guo Z; Hu M; Khan T; Murgolo N; Zhao L; Penington JS; Reaksudsan K; Jarman K; Dietrich MH; Richardson L; Guo KY; Lopaticki S; Tham WH; Rottmann M; Papenfuss T; Robbins JA; Boddey JA; Sleebs BE; Sabroux HJ; McCauley JA; Olsen DB; Cowman AF
Cell Host Microbe; 2020 Apr; 27(4):642-658.e12. PubMed ID: 32109369
[TBL] [Abstract][Full Text] [Related]
3. Recombinant expression and enzymatic subsite characterization of plasmepsin 4 from the four Plasmodium species infecting man.
Li T; Yowell CA; Beyer BB; Hung SH; Westling J; Lam MT; Dunn BM; Dame JB
Mol Biochem Parasitol; 2004 May; 135(1):101-9. PubMed ID: 15287591
[TBL] [Abstract][Full Text] [Related]
4. Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion.
Nasamu AS; Glushakova S; Russo I; Vaupel B; Oksman A; Kim AS; Fremont DH; Tolia N; Beck JR; Meyers MJ; Niles JC; Zimmerberg J; Goldberg DE
Science; 2017 Oct; 358(6362):518-522. PubMed ID: 29074774
[TBL] [Abstract][Full Text] [Related]
5. Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity.
Richardson LW; Ashton TD; Dans MG; Nguyen N; Favuzza P; Triglia T; Hodder AN; Ngo A; Jarman KE; Cowman AF; Sleebs BE
ChemMedChem; 2022 Sep; 17(18):e202200306. PubMed ID: 35906744
[TBL] [Abstract][Full Text] [Related]
6. A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress.
Pino P; Caldelari R; Mukherjee B; Vahokoski J; Klages N; Maco B; Collins CR; Blackman MJ; Kursula I; Heussler V; Brochet M; Soldati-Favre D
Science; 2017 Oct; 358(6362):522-528. PubMed ID: 29074775
[TBL] [Abstract][Full Text] [Related]
7. The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria.
de Lera Ruiz M; Favuzza P; Guo Z; Zhao L; Hu B; Lei Z; Zhan D; Murgolo N; Boyce CW; Vavrek M; Thompson J; Ngo A; Jarman KE; Robbins J; Boddey J; Sleebs BE; Lowes KN; Cowman AF; Olsen DB; McCauley JA
ACS Med Chem Lett; 2022 Nov; 13(11):1745-1754. PubMed ID: 36385924
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of plasmepsins I and II aspartic proteases of the Plasmodium falciparum digestive vacuole.
Luker KE; Francis SE; Gluzman IY; Goldberg DE
Mol Biochem Parasitol; 1996 Jul; 79(1):71-8. PubMed ID: 8844673
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes.
Hodder AN; Sleebs BE; Czabotar PE; Gazdik M; Xu Y; O'Neill MT; Lopaticki S; Nebl T; Triglia T; Smith BJ; Lowes K; Boddey JA; Cowman AF
Nat Struct Mol Biol; 2015 Aug; 22(8):590-6. PubMed ID: 26214367
[TBL] [Abstract][Full Text] [Related]
10. Mapping selectivity and specificity of active site of plasmepsins from Plasmodium falciparum using molecular interaction field approach.
Kumar A; Ghosh I
Protein Pept Lett; 2007; 14(6):569-74. PubMed ID: 17627598
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum ookinete expression of plasmepsin VII and plasmepsin X.
Li F; Bounkeua V; Pettersen K; Vinetz JM
Malar J; 2016 Feb; 15():111. PubMed ID: 26911483
[TBL] [Abstract][Full Text] [Related]
12. Expression and characterisation of plasmepsin I from Plasmodium falciparum.
Moon RP; Tyas L; Certa U; Rupp K; Bur D; Jacquet C; Matile H; Loetscher H; Grueninger-Leitch F; Kay J; Dunn BM; Berry C; Ridley RG
Eur J Biochem; 1997 Mar; 244(2):552-60. PubMed ID: 9119023
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and modelling of photoreactive chemical probes for investigating target engagement of plasmepsin IX and X in
Lisauskaitė M; Nixon GL; Woodley CM; Berry NG; Coninckx A; Qie LC; Leung SC; Taramelli D; Basilico N; Parapini S; Ward SA; Vadas O; Soldati-Favre D; Hong WD; O'Neill PM
RSC Chem Biol; 2024 Jan; 5(1):19-29. PubMed ID: 38179191
[TBL] [Abstract][Full Text] [Related]
14. Bridging the Gap in Malaria Parasite Resistance, Current Interventions, and the Way Forward from in Silico Perspective: A Review.
Kumi RO; Oti B; Abo-Dya NE; Alahmdi MI; Soliman MES
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432016
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.
Mohapatra SC; Tiwari HK; Singla M; Rathi B; Sharma A; Mahiya K; Kumar M; Sinha S; Chauhan SS
J Biol Inorg Chem; 2010 Mar; 15(3):373-85. PubMed ID: 19946719
[TBL] [Abstract][Full Text] [Related]
16. Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases.
Mukherjee B; Tessaro F; Vahokoski J; Kursula I; Marq JB; Scapozza L; Soldati-Favre D
EMBO J; 2018 Apr; 37(7):. PubMed ID: 29519896
[No Abstract] [Full Text] [Related]
17. Biochemical characterization of plasmepsin V from Plasmodium vivax Thailand isolates: Substrate specificity and enzyme inhibition.
Sappakhaw K; Takasila R; Sittikul P; Wattana-Amorn P; Assavalapsakul W; Boonyalai N
Mol Biochem Parasitol; 2015 Dec; 204(2):51-63. PubMed ID: 26795263
[TBL] [Abstract][Full Text] [Related]
18. Flap flexibility amongst plasmepsins I, II, III, IV, and V: Sequence, structural, and molecular dynamics analyses.
McGillewie L; Soliman ME
Proteins; 2015 Sep; 83(9):1693-705. PubMed ID: 26146842
[TBL] [Abstract][Full Text] [Related]
19. Macrocyclic Peptidomimetic Plasmepsin X Inhibitors with Potent
Kovada V; Withers-Martinez C; Bobrovs R; Ce Rule HN; Liepins E; Grinberga S; Hackett F; Collins CR; Kreicberga A; Jiménez-Díaz MB; Angulo-Barturen I; Rasina D; Suna E; Jaudzems K; Blackman MJ; Jirgensons A
J Med Chem; 2023 Aug; 66(15):10658-10680. PubMed ID: 37505188
[TBL] [Abstract][Full Text] [Related]
20. Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis.
Liu P; Marzahn MR; Robbins AH; Gutiérrez-de-Terán H; Rodríguez D; McClung SH; Stevens SM; Yowell CA; Dame JB; McKenna R; Dunn BM
Biochemistry; 2009 May; 48(19):4086-99. PubMed ID: 19271776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]